Paul Brannelly

Paul Brannelly serves as the Chief Financial Officer at Neurotech Pharmaceuticals, Inc. and Ribon Therapeutics, bringing extensive financial leadership experience from previous roles including Executive Vice President and Chief Financial Officer at Collegium Pharmaceutical, Inc. and Senior Vice President of Finance & Administration at Karyopharm Therapeutics Inc. In earlier career phases, Paul held the position of Vice President of Finance at Verastem. Academic credentials include a degree from UMass Amherst, earned between 1991 and 1995, alongside foundational education at Boston Latin School.